Hemispherian
Michael Lim is currently an advisor at Hemispherian. Prior to that, they were a professor of neurosurgery at The Johns Hopkins University School of Medicine from July 2007 to August 2020.
Michael Lim received their Doctor of Medicine (MD) from The Johns Hopkins University School of Medicine and their Bachelor of Science (BS) in Biochemistry from the University of New Hampshire.
This person is not in the org chart
This person is not in any offices
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.